Skip to main content

Bone Metastasis

Targeting initial tumour–osteoclast spatiotemporal interaction to prevent bone metastasis



Bone is the most common site of metastasis, and although low proliferation and immunoediting at the early stage make existing treatment modalities less effective, the microenvironment-inducing behaviour could be a target for early intervention.

Here we report on a spatiotemporal coupling interaction between tumour cells and osteoclasts, and named the tumour-associated osteoclast ‘tumasteoclast’—a subtype of osteoclasts in bone metastases induced by tumour-migrasome-mediated cytoplasmic transfer. We subsequently propose an in situ decoupling–killing strategy in which tetracycline-modified nanoliposomes encapsulating sodium bicarbonate and sodium hydrogen phosphate are designed to specifically release high concentrations of hydrogen phosphate ions triggered by tumasteoclasts, which depletes calcium ions and forms calcium-phosphorus crystals.

This can inhibit the formation of migrasomes for decoupling and disrupt cell membrane for killing, thereby achieving early prevention of bone metastasis. This study provides a research model for exploring tumour cell behaviour in detail and a proof-of-concept for behaviour-targeting strategy.

bone metastasis, skeletal-related events, cancer spread to bone, osteolytic lesions, osteoblastic lesions, bone pain, bone resorption, bone remodeling, tumor microenvironment, bone-targeted therapy, bisphosphonates, denosumab, bone scan, radionuclide therapy, pathological fracture, spinal cord compression, metastatic breast cancer, metastatic prostate cancer, bone marrow involvement, cancer-induced bone disease

#BoneMetastasis, #CancerSpread, #SkeletalHealth, #BoneLesions, #BonePain, #BoneOncology, #TumorInBone, #BoneTherapy, #Osteolytic, #Osteoblastic, #BoneMarkers, #Bisphosphonates, #Denosumab, #BoneScan, #CancerResearch, #OncologyCare, #MetastaticCancer, #BoneComplications, #SpinalCompression, #CancerTreatment


International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Award registration: genetics-conferences.healthcarek.com/award-registration/

For Enquiries: contact@healthcarek.com

Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
youtube.com/@GeneticsHealthcare

Comments

Popular posts from this blog

Chromosomal Abnormalities

  Chromosomal Abnormalities Chromosome abnormalities refer to structural or numerical changes in chromosomes that can disrupt normal genetic function, leading to developmental disorders, congenital abnormalities, and various genetic diseases. These abnormalities may arise from errors in cell division, such as nondisjunction or chromosomal breakage, resulting in conditions like Down syndrome , Turner syndrome, Klinefelter syndrome , and various deletion or duplication syndromes. Understanding chromosome abnormalities is essential for genetic counseling, prenatal diagnosis, disease risk assessment, and research in cytogenetics and molecular genetics. Chromosome abnormalities, chromosomal disorders, chromosomal mutations, aneuploidy, structural chromosome abnormalities, nondisjunction, deletion syndrome, duplication syndrome , translocation, inversion, cytogenetics, karyotyping, prenatal diagnosis , genetic testing, genomic instability, Down syndrome, Turner syndrome, Klinefelter syn...

Multifactorial Genetic Conditions

Multifactorial Genetic Conditions Multifactorial genetic conditions are disorders caused by the combined effects of multiple genes and environmental factors , rather than a single gene mutation . These conditions do not follow classic Mendelian inheritance patterns and instead result from complex gene–environment interactions . Factors such as lifestyle, nutrition, infections, stress, and exposure to toxins can significantly influence disease onset and severity in genetically susceptible individuals. Common examples include diabetes, cardiovascular diseases , neural tube defects, asthma, and many neuropsychiatric disorders. Understanding multifactorial inheritance is essential for risk prediction, preventive medicine, and personalized healthcare strategies. Multifactorial inheritance, polygenic traits, gene–environment interaction, complex diseases, genetic susceptibility, environmental risk factors, non-Mendelian inheritance, disease predisposition, polygenic risk score, precision ...

Wolf-Hirschhorn Syndrome

 Wolf-Hirschhorn Syndrome Wolf–Hirschhorn Syndrome (WHS) is a rare genetic disorder caused by a partial deletion of the short arm of chromosome 4 (4p16.3). It is characterized by distinct craniofacial features often described as a “Greek warrior helmet” appearance, along with growth retardation, intellectual disability, seizures, and developmental delay. Affected individuals may also present with hypotonia , congenital heart defects, skeletal abnormalities, and delayed speech and motor skills. The severity of symptoms varies depending on the size of the chromosomal deletion . WHS typically occurs sporadically, though it can be inherited through chromosomal rearrangements. Early diagnosis through genetic testing and multidisciplinary medical care are essential for improving quality of life and managing associated complications. Wolf–Hirschhorn Syndrome, WHS, chromosome 4p deletion, 4p16.3 deletion, rare genetic disorder, developmental delay, intellectual disability, seizures, cran...